Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
- Address
- Robert-Koch-Strasse 40, Weende, 37075 Göttingen, Germany
Neuroscience and Multiple Sclerosis Research
At the Fraunhofer Institute For Translational Medicine And Pharmacology ITMP in Goettingen, clinical research in Nervous System Diseases is focused on relapsing remitting multiple sclerosis. The studies are designed to evaluate new treatment options and better understand how they may support patients living with this chronic immune-mediated condition.
- Assessing the safety and tolerability of a new therapy for RRMS
- Exploring innovative approaches to improve treatment effectiveness in multiple sclerosis
This area reflects the site’s interest in developing better therapies for neurological disease while keeping patient safety central to the research.
Oncology and Bladder Cancer Studies
Another key focus is Neoplasms, with research centered on non-muscle invasive bladder cancer. These trials aim to test new treatment strategies for a cancer that remains confined to the bladder lining, with the goal of improving local disease control and patient outcomes.
- Evaluating a targeted treatment approach for non-muscle invasive bladder cancer
- Studying how new bladder-directed therapies may improve cancer management
The work at Fraunhofer ITMP highlights translational research that connects laboratory innovation with practical cancer care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Safety and Efficacy of CLS12311 in Patients with Relapsing Remitting Multiple Sclerosis: A Phase Ib/IIa Multicenter Study | Cellerys AG | Phase I | Not Recruiting | Apr 2024 | Dec 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cls12311 | 1 | Unknown | 2024-04-17 | 2024-04-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.